resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
b72d99fd-ee1e-42ec-92b6-9f89e375cce1,sNF02.2,['Cell Line'],"The sNF02.2 cell line was derived from a lung metastasis MPNST in an NF1 patient and exhibited a very weak full length NF1 band, indicating partial loss of the NF1 gene.","['Cell line origin', 'Genetics']",,,,https://doi.org/10.4137/TOG.S8830
b72d99fd-ee1e-42ec-92b6-9f89e375cce1,sNF02.2,['Cell Line'],"The sNF02.2 cell line exhibited increased phosphorylation of Erk1/2 compared to the normal HSC361 cell line, indicating increased MAPK activity.",['Signaling'],,,,https://doi.org/10.4137/TOG.S8830
b72d99fd-ee1e-42ec-92b6-9f89e375cce1,sNF02.2,['Cell Line'],"The sNF02.2 cell line was more resistant to drug treatments targeting PI3K, MEK, and mTOR pathways compared to the SNF10.1 and SNF96.2 cell lines.",['Drug response'],,,,https://doi.org/10.18632/oncotarget.25181
b72d99fd-ee1e-42ec-92b6-9f89e375cce1,sNF02.2,['Cell Line'],"The sNF02.2 cell line harbors a missense mutation D1623V in the NF1 gene transcript variant 1 NM_001042492, with no detectable second mutation.",['Genetics'],,,,https://doi.org/10.18632/oncotarget.25181
